ArticleScience translational medicine2020

Regulatory T cells engineered with TCR signaling-responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter.

Siawosh K Eskandari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.